Drug Screening Market is Expected to Reach $11.6 billion | MarketsandMarkets.

Chicago, Aug. 21, 2023 (GLOBE NEWSWIRE) -- In the near future, the drug screening industry is poised to undergo a transformative evolution driven by rapid technological advancements and an increasing emphasis on personalized medicine. Cutting-edge technologies such as high-throughput screening, artificial intelligence, and advanced biomarker detection methods will enable more efficient and accurate identification of potential drug candidates, significantly accelerating the drug discovery process. Precision medicine approaches will become increasingly prevalent, tailoring drug screening strategies to individual patients' genetic profiles and health conditions, leading to more targeted and effective treatments. Moreover, the integration of wearable devices, point-of-care testing, and telemedicine will facilitate widespread and convenient drug screening applications, extending beyond clinical settings to empower proactive health management in everyday life. As regulatory frameworks adapt to these innovations, collaborations among pharmaceutical companies, research institutions, technology providers, and healthcare stakeholders will shape a dynamic landscape that strives for safer medications, expedited drug development, and improved patient outcomes.

Drug Screening market in terms of revenue was estimated to be worth $5.3 billion in 2021 and is poised to reach $11.6 billion by 2026, growing at a CAGR of 16.8% from 2021 to 2026 according to a latest report published by MarketsandMarkets™. Growth in this market is attributed to the growing drug & alcohol consumption and the enforcement of stringent laws mandating drug & alcohol testing, rising regulatory approvals for drug screening products & services. On the other hand, bans on alcohol consumption in Islamic countries and prohibitions on workplace drug testing in specific countries are some major factors that may hinder market growth.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773

Drug Screening Market Scope:

Report Coverage	Details
Market Revenue in 2021	$5.3 billion
Estimated Value by 2026	$11.6 billion
Growth Rate	Poised to grow at a CAGR of 16.8%
Market Size Available for	2019-2026
Forecast Period	2021–2026
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Product & Service, Sample type, End User, and Region
Geographies Covered	North America (the US and Canada), Asia Pacific (Japan, China, India, and RoPAC), Europe (Germany, UK, France, Italy, Spain and RoE), and the Rest of the World (Latin America, Middle East & Africa)
Report Highlights	Updated financial information / product portfolio of players
Key Market Opportunities	Emerging economies
Key Market Drivers	Growing drug and alcohol consumption

Drug Screening market major players covered in the report, such as:

• LabCorp (US)
• Quest Diagnostics (US)
• Abbott Laboratories (US)
• Thermo Fisher Scientific, Inc. (US)
• Alfa Scientific Designs, Inc. (US)
• OraSure Technologies, Inc. (US)
• Siemens Healthineers (Germany)
• Roche (Switzerland)
• MPD Inc. (US)
• Shimadzu (Japan)
• LifeLoc Technologies (US)
• Drägerwerk (Germany)
• Premier Biotech, Inc. (US)
• Omega Laboratories, Inc. (US)
• Psychemedics (US)
• Clinical Reference Laboratory (US)
• American Bio Medica Corporation (US)
• ACM Global Laboratories (US)
• CareHealth America Corp (US)
• Sciteck, Inc. (US)
• Synens (France)
• Intoximeters (US)
• AccuSource (US)
• Cordant Health Solutions (US)
• Millennium Health (US)
• and Among Others

Buy a Drug Screening Industry Report (223 Pages PDF with Insightful Charts, Tables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=162987773

The study categorizes the Drug screening market into the following segments and subsegments:

By Product and Service

• Drug Screening Product
  • Analytical Instruments
    • Breathalyzers
      • Fuel Cell Breathalyzer
      • Semiconductor Breathalyzer
      • Other Breathalyzers
    • Immunoassay Analyzer
    • Chromatography Instruments
  • Rapid Testing Devices
    • Urine Testing Devices
      • Drug Testing Cups
      • Dip Cards
      • Drug Testing Cassetts
    • Oral Fluid Testing Devices
  • Consumables
    • Assay Kits
    • Sample Collection Devices
    • Calibrators & Controls
    • Other Consumables
• Drug Screening Service

By Sample Type

• Urine Samples
• Breath Samples
• Oral Fluid Samples
• Hair Samples
• Other Samples

By End User

• Drug Testing Laboratories
• Workplaces
• Criminal Justice and Law Enforcement Agencies
• Hospitals
• Drug Treatment Centers
• Individual Users
• Pain Management Centers
• Schools and Colleges     

By Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • RoE
• Asia Pacific
  • China
  • Japan
  • India
  • RoAPAC
  • Rest of the World 
• Latin America
• Middle East & Africa

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=162987773

The key stakeholders in the Drug Screening market include:

• Pharmaceutical Companies: These companies are involved in drug discovery and development, and they often utilize drug screening methods to identify potential candidate compounds for further research and clinical trials.
• Biotechnology Companies: Similar to pharmaceutical companies, biotech firms are engaged in developing innovative drugs and therapies. They may also use drug screening techniques to identify promising compounds.
• Research Institutions and Academia: Universities, research institutes, and academic laboratories contribute to drug screening research, technology development, and education. They may collaborate with other stakeholders and conduct fundamental research in this field.
• Contract Research Organizations (CROs): CROs specialize in providing outsourced research services to pharmaceutical and biotechnology companies. They often conduct drug screening assays and studies on behalf of their clients.
• Diagnostic Companies: These companies focus on developing and providing drug screening tests for various purposes, including workplace drug testing, clinical diagnostics, and drug abuse monitoring.
• Government Agencies and Regulatory Authorities: Regulatory agencies like the Food and Drug Administration (FDA) in the United States and their counterparts in other countries oversee the safety and efficacy of drugs. They establish guidelines for drug screening and approve new drugs for market entry.
• Healthcare Providers: Hospitals, clinics, and medical practices may implement drug screening tests to monitor patient compliance with prescribed medications, detect drug abuse, and ensure patient safety.
• Pharmacists: Pharmacists play a role in dispensing medications and educating patients about proper medication use, including potential interactions and side effects.
• Patients and Consumers: Individuals who take prescription medications or over-the-counter drugs may be subject to drug screening tests to ensure they are using their medications as directed and to identify any potential issues.
• Insurance Companies: Insurance providers may be interested in drug screening to assess risk and determine coverage policies related to medication use.
• Ethics Committees and Institutional Review Boards (IRBs): These bodies ensure that research involving human subjects follows ethical guidelines and safety regulations. They play a role in reviewing and approving clinical trials that involve drug screening.
• Technology Providers: Companies that develop and supply drug screening technologies, such as high-throughput screening systems, laboratory equipment, and software, are integral to the market.
• Legal and Regulatory Consultants: Legal experts and consultants provide guidance to companies navigating the complex regulatory landscape related to drug screening, ensuring compliance with relevant laws and regulations.
• Advocacy Groups: Non-profit organizations and advocacy groups may work to raise awareness about the importance of drug screening, push for policy changes, and support research efforts.
• Investors and Venture Capitalists: Financial stakeholders who invest in pharmaceutical, biotechnology, and diagnostic companies contribute to the growth and innovation of the drug screening market.

These stakeholders collectively shape the drug screening market, influencing its development, adoption, and impact on public health and safety.

Recent Developments:

• In August 2021, Quest Diagnostics and Select Health of South Carolina entered into an agreement to expand Select Health’s laboratory network for its Medicaid and Medicare-Medicaid dual-eligible enrollees and to enhance access to diagnostics information services for members.
• In September 2020, LabCorp Entered into a multi-year agreement with Infirmary Health (US) to offer laboratory testing services in the eastern Gulf Coast.
• In May 2020, Psychemedics introduced a vaping panel test that detects the ingestion of marijuana, CBD, and nicotine drugs by all methods, including electronic cigarettes or smoking
• In April 2019, Thermo Fisher Scientific introduced CEDIA Mitragynine (Kratom) Assay for the detection of Kratom for criminal justice and forensic use only
• In May 2018, Omega Laboratories introduced the Omega Hair 17-panel drug test capable of detecting 45 different substances, including eight commonly abused variants of benzodiazepines

Frequently Asked Questions (FAQs) of Drug Screening Market:

Question1. What is the impact of COVID-19 on the drug screening market?
Answer: The COVID-19 (coronavirus) outbreak has disrupted business and economic activities globally. It is expected to have a short-term impact on the Drug screening market to a certain extent.

Question 2. Who are the key players in the drug screening market?
Answer: The prominent players operating in this market include LabCorp (US), Quest Diagnostics (US), Abbott Laboratories (US), OraSure Technologies (US), Alfa Scientific Designs (US), LifeLoc (US), Omega Laboratories (US), Premier Biotech (US).

Question 3: Which product and service segment dominates in the Drug screening market?
Answer: Services segment expected to dominate the drug screening market, mainly due to the growing drug & alcohol consumption worldwide, funding initiatives for drug testing laboratories, service launches and regulatory approvals, and geographic expansion of drug testing laboratories.

Question 4: Which end user segment of the global drug screening market is expected to witness the highest growth?
Answer: Drug Testing laboratories is expected to witness the highest growth.

Question 5: What is the market for drug screening?
Answer: The global drug screening market is projected to reach USD 11.6 billion by 2026, from USD 5.3 billion in 2021, at a CAGR of 16.8% during the forecast period.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=162987773

Report Objectives:

• To define, describe, and forecast the global drug screening market based on the product and service, sample type, end user and region.
• To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities).
• To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall drug screening market.
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
• To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World.
• To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies.
• To track and analyze competitive developments such as acquisitions, product and services launches, approvals, expansions, agreements, partnerships, and R&D activities in the drug screening market.

Related Reports:

Clinical Chemistry Analyzers Market

Life Science Instrumentation Market

Breath Analyzer Market

Cannabis Testing Market

Specimen Validity Testing Market

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/drug-alcohol-screening-market.asp

Content Source: https://www.marketsandmarkets.com/PressReleases/drug-alcohol-screening.asp

            About MarketsandMarkets™

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com